AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

The Collagen Factors of Rapid Progression of Keratoconus in Children.

Recruitingn/aAges 10 Years - 50 YearsAllZhongshan Ophthalmic Center, Sun Yat-sen Universiโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The purpose of this observational study was to understand the differences in clinical features and mechanisms of keratoconus between children and adults. The main questions it aimed to answer as follows: (1) to understand the characteristics of keratoconus in Chinese children. (2) to observe corneal stromal cells at the cytological level using in vivo corneal laser confocal microscopy and explore the pathogenesis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * โ‘  Patients with keratoconus who visit the refractive clinic. 1. The height of the posterior corneal surface is greater than 16 microns under the Pentacam corneal topography. 2. ARTAve \< 424 microns, ARTMax \< 339 microns. 3. Clinical non-inflammatory or traumatic corneal thinning and corneal astigmatism. * Aged between 10 and 50 years old, no gender restrictions. * Agree to accept and complete follow-up examinations on time. โ‘ฃ I and my guardian understand and agree to participate in this clinical trial and sign the informed consent form. Exclusion Criteria: * โ‘  There is a history of contact lens wearing in the last four weeks. * poor fixation and can not cooperate with the examination. โ‘ข History of eye trauma and surgery (including corneal collagen cross-linking surgery). * History of other related eye diseases: corneal disease, glaucoma, retinal choroid disease, etc.. โ‘ค severe eye diseases affecting imaging such as dry eye, conjunctivitis and pterygium. โ‘ฅ Any systemic disease affecting eye morphology and refractive interstitium.
๐Ÿ’Š

What it tests

  • Observation
๐Ÿ“

Where

1 site
Zhongshan Ophthalmic Center,Sun Yat-Sen University
Guangzhou, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy